|
Abdallah Nemer M.N., Belousov I.I., Kogan M.I., Goncharova Z.A., Belousova M.E.
Efficacy and safety of the polypeptide drug «Vesusten» in the correction of neurogenic LUTS in Multiple Sclerosis. Results of the pilot study
|
№3 / 2024
|
|
V.V. Borisov
Overactive bladder – pathogenetic features and choice of drug therapy
|
№2 / 2021
|
|
Z.K. Gadzhieva, Yu.B. Kazilov
VValidation of the combined medical therapy for LUTS using α1-adrenergic blockers and M-cholinoblockers
|
№1 / 2016
|
|
D.V. Ergakov, A.G. Martov
The Modern View of Conservative Therapy of Lower Urinary Tract Symptoms in Men
|
№5 / 2015
|
|
A. Mangera, C. Chapple
An evidence based update on the investigation and management of male lower urinary tract symptoms
|
№2 / 2015
|
|
Z.K. Gadzhieva
Positive effect of increasing dosage of selective antimuscarinics on the main symptoms of overactive bladder
|
№4 / 2014
|
|
Z.K. Gadzhieva, Yu.B. Kazilov, Yu.G.Alyaev, I.A. Aboyan, B.R. Kazilov
Urination disorders. Do we know all about them?
|
№1 / 2014
|
|
Yu.G. Alyaev, Z.K. Gadzhieva, L.M. Rapoport, D.G. Tsarichenko, Yu.B. Kazilov
Imperative and obstructive urination disorders in patients with chronic inflammatory diseases of the urinary
|
№1 / 2013
|
|
V.A. Maksimov, L.A. Khodyreva, A.A. Dudareva
The use of tolterodine in patients with recurrent chronic cystitis
|
№4 / 2012
|
Русский
